Meritage Portfolio Management’s MaxLinear MXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-14,498
Closed -$458K 338
2023
Q2
$458K Buy
14,498
+4,410
+44% +$127K 0.03% 249
2023
Q1
$355K Buy
10,088
+1,977
+24% +$71.6K 0.03% 230
2022
Q4
$275K Buy
8,111
+361
+5% +$12.2K 0.02% 264
2022
Q3
$253K Buy
+7,750
New +$287K 0.02% 268
2022
Q1
Sell
-3,613
Closed -$272K 371
2021
Q4
$272K Buy
+3,613
New +$231K 0.02% 281
2017
Q3
Sell
-240,839
Closed -$6.72M 210
2017
Q2
$6.72M Sell
240,839
-6,096
-2% -$178K 0.69% 39
2017
Q1
$6.93M Buy
246,935
+2,440
+1% +$62.6K 0.73% 34
2016
Q4
$5.33M Sell
244,495
-2,355
-1% -$48.8K 0.58% 73
2016
Q3
$5M Buy
+246,850
New +$4.85M 0.55% 81

Other funds holding MXL

Meritage Portfolio Management's MXL Position: Q3 2023 in Review

Meritage Portfolio Management sold out of MaxLinear (MXL) in Q3 2023, closing a stake of 14,498 shares — an estimated $458K sold.

Meritage Portfolio Management first reported a position in MXL in Q3 2016 and held it in 9 quarters. The position peaked at $6.93M in Q1 2017. 231 funds tracked by Wall St. Rank hold MXL as of Q3 2023.

  • Meritage Portfolio Management reported no remaining MaxLinear position as of Q3 2023 after selling out during the quarter.
  • Meritage Portfolio Management sold 14,498 MaxLinear shares in Q3 2023, an estimated $458K.
  • Meritage Portfolio Management first reported a position in MaxLinear in Q3 2016 and held it in 9 quarters.
  • Meritage Portfolio Management's MaxLinear position peaked at $6.93M in Q1 2017.
  • 231 funds tracked by Wall St. Rank held MaxLinear as of Q3 2023.

Based on Meritage Portfolio Management's 13F filing for Q3 2023, filed 30 Oct 2023.